☆ 4.6 Article

A significant proportion of classic Hodgkin lymphoma recurrences represents clonally unrelated second primary lymphoma

BLOOD ADVANCES (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Review Hematology

CHIPing away the progression potential of CHIP: A new reality in the making

Zhuoer Xie et al.

Summary: In recent years, there has been an increased understanding of the epidemiology, clinical implications, and mechanistic aspects of clonal hematopoiesis of indeterminate potential (CHIP). However, interventions to prevent or delay the negative consequences of CHIP are still lacking. This review highlights the latest updates on CHIP research, including molecular mechanisms and clinical implications, with a focus on the evolving strategies for interventions in ongoing trials. Standardized and evidence-based recommendations and guidelines are urgently needed for the evaluation and management of individuals with clonal hematopoiesis. Patient-centric endpoints must also be defined for clinical trials to further develop effective preventive strategies and improve clinical outcomes.

BLOOD REVIEWS (2023)

添加到收藏夹

Article Hematology

Discovery of novel predisposing coding and noncoding variants in familial Hodgkin lymphoma

Jamie E. Flerlage et al.

Summary: Familial aggregation of HL has been shown to have a genetic component. In this study, whole genome sequencing was performed on individuals with and without HL from pedigrees with multiple affected relatives. A total of 44 HL-risk variants were identified, including both coding and noncoding variants. The study also identified several novel variants and observed segregation patterns in most pedigrees.

BLOOD (2023)

添加到收藏夹

Review Hematology

Pathology review identifies frequent misdiagnoses in recurrent classic Hodgkin lymphoma in a nationwide cohort: implications for clinical and epidemiological studies

Max V. Boot et al.

Summary: A study in the Netherlands re-evaluated the risk of developing non-Hodgkin lymphoma (NHL) after classic Hodgkin lymphoma (CHL) treatment and identified pathological features that resemble CHL. The study found that the risk of developing NHL after CHL treatment is lower than previously reported and highlighted the importance of accurate diagnosis and treatment.

HAEMATOLOGICA (2023)

添加到收藏夹

Letter Oncology

Synchronous diffuse large B-cell lymphoma and mantle cell lymphoma: support for low-threshold biopsies and genetic testing

Fleur A. de Groot et al.

LEUKEMIA & LYMPHOMA (2022)

添加到收藏夹

Article Pathology

Clonality assessment and detection of clonal diversity in classic Hodgkin lymphoma by next-generation sequencing of immunoglobulin gene rearrangements

Diede A. G. van Bladel et al.

Summary: The clonality analysis plays an important role in diagnosing classic Hodgkin lymphoma, especially in cases with atypical presentation or histology resembling T cell lymphoma and patients with recurrent disease. The development of a novel NGS-based assay has significantly improved the detection of clonal gene rearrangements in cHL cases, particularly in formalin-fixed paraffin-embedded tissue specimens, demonstrating increased sensitivity and performance compared to conventional methods.

MODERN PATHOLOGY (2022)

添加到收藏夹

Article Hematology

Late recurrence of lymphoid malignancies after initial treatment for Hodgkin lymphoma - A study from the Danish Lymphoma Registry

Maja Dam Andersen et al.

Summary: We analysed a large cohort of Hodgkin lymphoma patients to determine the pattern of late recurrence, the influential factors, and the outcome for patients experiencing recurrence.

BRITISH JOURNAL OF HAEMATOLOGY (2022)

添加到收藏夹

Review Hematology

Game of clones: Diverse implications for clonal hematopoiesis in lymphoma and multiple myeloma

Jeremy Meier et al.

Summary: Clonal hematopoiesis is common in patients with blood cancers, correlated with inflammation, and can impact lymphoma and multiple myeloma through various mechanisms.

BLOOD REVIEWS (2022)

添加到收藏夹

Letter Oncology

Very late relapses in Hodgkin lymphoma treated with chemotherapy with or without radiotherapy: linear pattern and distinct prognostic factors

Theodoros P. Vassilakopoulos et al.

BLOOD CANCER JOURNAL (2022)

添加到收藏夹

Review Oncology

Novel Approaches in Molecular Characterization of Classical Hodgkin Lymphoma

Diede A. G. van Bladel et al.

Summary: This review provides an overview of recent advances in genotyping the clonal and mutational landscape of classical Hodgkin lymphoma (cHL). The authors discuss the application of next-generation sequencing in the diagnosis and treatment of cHL, as well as its contribution to understanding the pathogenesis of cHL.

CANCERS (2022)

添加到收藏夹

Review Medicine, General & Internal

Classical Hodgkin lymphoma

Pauline Brice et al.

Summary: Classical Hodgkin lymphoma is a relatively common lymphoma that is generally considered highly curable with standard first-line chemotherapy and radiotherapy, although some patients may not be cured or may experience late toxic effects leading to premature death. Recent changes in the gold standard of chemotherapy, now often including immunotherapy in relapse settings, have further impacted treatment outcomes.

LANCET (2021)

添加到收藏夹

Review Oncology

Molecular biology of Hodgkin lymphoma

Marc A. Weniger et al.

Summary: Classical Hodgkin lymphoma (cHL) has unique biological features such as the orchestration of a complex microenvironment by HRS cells, the major role of Epstein-Barr virus in lymphomagenesis, and the defining interplay of genetic lesions and cellular origin. These factors contribute to the constitutive activation of multiple signaling pathways in cHL.

LEUKEMIA (2021)

添加到收藏夹

Article Oncology

Molecular Progression of Myeloproliferative and Myelodysplastic/Myeloproliferative Neoplasms: A Study on Sequential Bone Marrow Biopsies

Magdalena M. Brune et al.

Summary: The study identified specific mutations that promote progression in myeloid neoplasms patients and found that patients with progression have more genetic alterations. Furthermore, it emphasized the importance of both the quantity and order of genetic alterations in disease evolution.

CANCERS (2021)

添加到收藏夹

Review Pathology

How I Diagnose Angioimmunoblastic T-Cell Lymphoma

Yi Xie et al.

Summary: AITL, a subtype of peripheral T-cell lymphoma derived from T-follicular helper cells, poses diagnostic challenges due to its wide clinical and histopathologic spectrum. Diagnostic tools and molecular studies play crucial roles in aiding accurate diagnosis and differential diagnosis.

AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2021)

添加到收藏夹

Article Pathology

Next-Generation Sequencing-Based Clonality Assessment of Ig Gene Rearrangements A Multicenter Validation Study by EuroClonality-NGS

Michiel van den Brand et al.

Summary: NGS-based IG clonality analysis shows high interlaboratory concordance and concordance with conventional analysis, with a higher ability to detect clonal rearrangements. NGS and conventional analysis detect clonality in 96% and 95% of B-cell neoplasms, respectively, with the majority of reactive cases being polyclonal.

JOURNAL OF MOLECULAR DIAGNOSTICS (2021)

添加到收藏夹

Article Oncology

Dissecting Clonal Hematopoiesis in Tissues of Patients with Classic Hodgkin Lymphoma

Alessandra Venanzi et al.

Summary: The study found that clonal hematopoiesis could be present in the tissue of classic Hodgkin lymphoma (cHL), give rise to the tumor clone, and spread to large parts of its microenvironment. Even when massive, clonal hematopoiesis does not always lead to the neoplastic clone of multiple myeloid and lymphoid neoplasms occurring in the same patient.

BLOOD CANCER DISCOVERY (2021)

添加到收藏夹

Article Hematology

An intronic deletion in megakaryoblastic leukemia 1 is associated with hyperproliferation of B cells in triplets with Hodgkin lymphoma

Julien Record et al.

HAEMATOLOGICA (2020)

添加到收藏夹

Article Oncology

CTLA4 haploinsufficiency as a predisposition to classical Hodgkin lymphoma

Upendra Mahat et al.

PEDIATRIC HEMATOLOGY AND ONCOLOGY (2020)

添加到收藏夹

Article Biotechnology & Applied Microbiology

Identification of Familial Hodgkin Lymphoma Predisposing Genes Using Whole Genome Sequencing

Aayushi Srivastava et al.

FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2020)

添加到收藏夹

Article Pathology

Evaluation of a Hybrid Capture-Based Pan-Cancer Panel for Analysis of Treatment Stratifying Oncogenic Aberrations and Processes

Leonie I. Kroeze et al.

JOURNAL OF MOLECULAR DIAGNOSTICS (2020)

添加到收藏夹

Review Medicine, General & Internal

Hodgkin Reed-Sternberg-Like Cells in Non-Hodgkin Lymphoma

Paola Parente et al.

DIAGNOSTICS (2020)

添加到收藏夹

Article Oncology

Relapse Risk and Loss of Lifetime After Modern Combined Modality Treatment of Young Patients With Hodgkin Lymphoma: A Nordic Lymphoma Epidemiology Group Study

Jorne Lionel Biccler et al.

JOURNAL OF CLINICAL ONCOLOGY (2019)

添加到收藏夹

Article Pathology

The pathological features of angioimmunoblastic T-cell lymphomas with IDH2R172 mutations

Julia Steinhilber et al.

MODERN PATHOLOGY (2019)

添加到收藏夹

Article Oncology

Next-generation sequencing of immunoglobulin gene rearrangements for clonality assessment: a technical feasibility study by EuroClonality-NGS

Blanca Scheijen et al.

LEUKEMIA (2019)

添加到收藏夹

Article Oncology

Standardized next-generation sequencing of immunoglobulin and T-cell receptor gene recombinations for MRD marker identification in acute lymphoblastic leukaemia; a EuroClonality-NGS validation study

Monika Brueggemann et al.

LEUKEMIA (2019)

添加到收藏夹

Letter Medicine, General & Internal

High-Risk Clonal Hematopoiesis as the Origin of AITL and NPM1-Mutated AML

Enrico Tiacci et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

添加到收藏夹

Review Oncology

Hodgkin Lymphoma: A Review and Update on Recent Progress

Satish Shanbhag et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2018)

添加到收藏夹

Article Biochemical Research Methods

ARResT/Interrogate: an interactive immunoprofiler for IG/TR NGS data

Vojtech Bystry et al.

BIOINFORMATICS (2017)

添加到收藏夹

Article Oncology

Early Positron Emission Tomography Response-Adapted Treatment in Stage I and II Hodgkin Lymphoma: Final Results of the Randomized EORTC/LYSA/FIL H10 Trial

Marc P. E. Andre et al.

JOURNAL OF CLINICAL ONCOLOGY (2017)

添加到收藏夹

Article Oncology

Late Relapse of Classical Hodgkin Lymphoma: An Analysis of the German Hodgkin Study Group HD7 to HD12 Trials

Paul J. Broeckelmann et al.

JOURNAL OF CLINICAL ONCOLOGY (2017)

添加到收藏夹

Article Medicine, General & Internal

PET-guided treatment in patients with advanced-stage Hodgkin's lymphoma (HD18): final results of an open-label, international, randomised phase 3 trial by the German Hodgkin Study Group

Peter Borchmann et al.

LANCET (2017)

添加到收藏夹

Article Oncology

HLA dependent immune escape mechanisms in B-cell lymphomas: Implications for immune checkpoint inhibitor therapy?

Marcel Nijland et al.

ONCOIMMUNOLOGY (2017)

添加到收藏夹

Article Hematology

Whole exome sequencing in families at high risk for Hodgkin lymphoma: identification of a predisposing mutation in the KDR gene

Melissa Rotunno et al.

HAEMATOLOGICA (2016)

添加到收藏夹

Article Oncology

Evaluation of the Risk of Relapse in Classical Hodgkin Lymphoma at Event-Free Survival Time Points and Survival Comparison With the General Population in British Columbia

Greg Hapgood et al.

JOURNAL OF CLINICAL ONCOLOGY (2016)

添加到收藏夹

Article Oncology

Eight Cycles of ABVD Versus Four Cycles of BEACOPPescalated Plus Four Cycles of BEACOPPbaseline in Stage III to IV, International Prognostic Score ≥ 3, High-Risk Hodgkin Lymphoma: First Results of the Phase III EORTC 20012 Intergroup Trial

Patrice Carde et al.

JOURNAL OF CLINICAL ONCOLOGY (2016)

添加到收藏夹

Article Hematology

Whole exome sequencing in families at high risk for Hodgkin lymphoma: identification of a predisposing mutation in the KDR gene

Melissa Rotunno et al.

HAEMATOLOGICA (2016)

添加到收藏夹

Article Medical Laboratory Technology

Reed-Sternberg–Like Cells in Non-Hodgkin Lymphomas

Juan C. Gomez-Gelvez et al.

ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2015)

添加到收藏夹

Letter Hematology

Identification of homozygous deletion in ACAN and other candidate variants in familial classical Hodgkin lymphoma by exome sequencing

Heikki Ristolainen et al.

BRITISH JOURNAL OF HAEMATOLOGY (2015)

添加到收藏夹

Article Hematology

A targeted mutational landscape of angioimmunoblastic T-cell lymphoma

Oreofe Odejide et al.

BLOOD (2014)

添加到收藏夹

Review Oncology

Genetic Associations in Classical Hodgkin Lymphoma: A Systematic Review and Insights into Susceptibility Mechanisms

Kushi Kushekhar et al.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2014)

添加到收藏夹

Article Multidisciplinary Sciences

A meta-analysis of Hodgkin lymphoma reveals 19p13.3 TCF3 as a novel susceptibility locus

W. Cozen et al.

NATURE COMMUNICATIONS (2014)

添加到收藏夹

Article Oncology

Relapsed Hodgkin Lymphoma: Management Strategies

Francesca Montanari et al.

CURRENT HEMATOLOGIC MALIGNANCY REPORTS (2014)

添加到收藏夹

Article Pathology

Clonality testing of malignant lymphomas with the BIOMED-2 primers in a large cohort of 1969 primary and consultant biopsies

Sylvia Hartmann et al.

PATHOLOGY RESEARCH AND PRACTICE (2013)

添加到收藏夹

Article Pathology

Follicular Peripheral T-cell Lymphoma Expands the Spectrum of Classical Hodgkin Lymphoma Mimics

Julien Moroch et al.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2012)

添加到收藏夹

Article Multidisciplinary Sciences

HLA Associations in Classical Hodgkin Lymphoma: EBV Status Matters

Xin Huang et al.

PLOS ONE (2012)

添加到收藏夹

Article Hematology

Association of JAK-STAT pathway related genes with lymphoma risk: results of a European case-control study (EpiLymph)

Katja Butterbach et al.

BRITISH JOURNAL OF HAEMATOLOGY (2011)

添加到收藏夹

Article Oncology

Clonal Relationship of Classical Hodgkin Lymphoma and Its Recurrences

Ellen C. Obermann et al.

CLINICAL CANCER RESEARCH (2011)

添加到收藏夹

Article Biochemistry & Molecular Biology

Hodgkin Disease Risk: Role of Genetic Polymorphisms and Gene-Gene Interactions in Inflammation Pathway Genes

Claudia M. Monroy et al.

MOLECULAR CARCINOGENESIS (2011)

添加到收藏夹

Article Hematology

IRF4 polymorphism rs872071 and risk of Hodgkin lymphoma

Peter Broderick et al.

BRITISH JOURNAL OF HAEMATOLOGY (2010)

添加到收藏夹

Letter Oncology

Rare presentation of classical Hodgkin lymphoma with a clonal T-cell receptor gene rearrangement in the tissue

Tudung T. Nguyen et al.

LEUKEMIA & LYMPHOMA (2010)

添加到收藏夹

Article Multidisciplinary Sciences

HLA-A alleles and infectious mononucleosis suggest a critical role for cytotoxic T-cell response in EBV-related Hodgkin lymphoma

Henrik Hjalgrim et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)

添加到收藏夹

Article Hematology

HLA-A02 is associated with a reduced risk and HLA-A01 with an increased risk of developing EBVI Hodgkin lymphoma

Marijke Niens et al.

BLOOD (2007)

添加到收藏夹

Article Genetics & Heredity

Gene polymorphisms in Toll-like receptors, interleukin-10, and interleukin-10 receptor alpha and lymphoma risk

A. Nieters et al.

GENES AND IMMUNITY (2006)

添加到收藏夹

Article Pathology

Rare expression of T-cell markers in classical Hodgkin's lymphoma

A Tzankov et al.

MODERN PATHOLOGY (2005)

添加到收藏夹

Article Oncology

Familial aggregation of Hodgkin lymphoma and related tumors

LR Goldin et al.

CANCER (2004)

添加到收藏夹

Article Hematology

Hodgkin and Reed-Sternberg cells represent an expansion of a single clone originating from a germinal center B-cell with functional immunoglobulin gene rearrangements but defective immunoglobulin transcription

T Marafioti et al.

BLOOD (2000)

添加到收藏夹

Article Immunology

Rare occurrence of classical Hodgkin's disease as a T cell lymphoma

M Müschen et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2000)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.